Skip to main content
Erschienen in: Journal of Clinical Immunology 7/2022

Open Access 13.06.2022 | Original Article

Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized Features

Erschienen in: Journal of Clinical Immunology | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract 

Purpose

Chronic granulomatous disease (CGD) is an uncommon, inborn error of immunity. We updated our large, single-center US experience with CGD and describe some newly recognized features.

Methods

We retrospectively reviewed 26 patients seen from November 2013 to December 2019. Serious infections required intravenous antibiotics or hospitalization.

Results

There were 21 males and 5 females. The most frequent infectious agents at presentation were aspergillus (4), serratia (4), burkholderia (2), Staphylococcus aureus (2), and klebsiella (2). The most common serious infections at presentation were pneumonia (6), lymphadenitis (6), and skin abscess (3). Our serious infection rate was 0.2 per patient-year from December 2013 through November 2019, down from 0.62 per patient-year from the previous study period (March 1985–November 2013). In the last 6 years, four patients were evaluated for human stem cell transplantation, two were successfully transplanted, and we had no deaths. Several patients had unusual infections or autoimmune manifestations of disease, such as pneumocystis pneumonia, basidiomycete/phellinus fungal pneumonia, and retinitis pigmentosa. We included one carrier female with unfavorable Lyonization in our cohort.

Conclusion

We update of a large US single-center experience with CGD and describe some recently identified features of the illness.
Literatur
1.
Zurück zum Zitat Baldridge CW, Gerard RW. The extra respiration of phagocytosis. Am J Physiol. 1932;103(1):235–6.CrossRef Baldridge CW, Gerard RW. The extra respiration of phagocytosis. Am J Physiol. 1932;103(1):235–6.CrossRef
2.
Zurück zum Zitat Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood. Am J Dis Child. 1959;97(4):387–408.CrossRef Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood. Am J Dis Child. 1959;97(4):387–408.CrossRef
3.
Zurück zum Zitat Johnston RB, McMurry JS. Chronic familial granulomatosis: report of five cases and review of the literature. Amer J Dis Child. 1967;114:370–8.CrossRefPubMed Johnston RB, McMurry JS. Chronic familial granulomatosis: report of five cases and review of the literature. Amer J Dis Child. 1967;114:370–8.CrossRefPubMed
4.
Zurück zum Zitat Segal AW, Cross AR, Garcia RC, et al. Absence of cytochrome b-245 in chronic granulomatous disease – a multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983;308(5):245–51.CrossRefPubMed Segal AW, Cross AR, Garcia RC, et al. Absence of cytochrome b-245 in chronic granulomatous disease – a multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983;308(5):245–51.CrossRefPubMed
5.
Zurück zum Zitat Ahlin A, De Boer M, Roos D, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84:1386–94.CrossRefPubMed Ahlin A, De Boer M, Roos D, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84:1386–94.CrossRefPubMed
6.
Zurück zum Zitat Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79(3):155–69.CrossRefPubMed Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79(3):155–69.CrossRefPubMed
7.
Zurück zum Zitat Jones LBKR, McGrogan P, Flood TY, et al. Special article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211–8.CrossRefPubMedPubMedCentral Jones LBKR, McGrogan P, Flood TY, et al. Special article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211–8.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Wolach B, Gavrieli R, de Boer M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129:103–14.CrossRefPubMed Wolach B, Gavrieli R, de Boer M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129:103–14.CrossRefPubMed
9.
Zurück zum Zitat Van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: the European experience. PLoS ONE 2009;4(4)L:e5234. Van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: the European experience. PLoS ONE 2009;4(4)L:e5234.
14.
15.
Zurück zum Zitat Carson MJ, Chadwick DL, Brubaker CL, Cleland RS, Landing BH. Thirteen boys with progressive septic granulomatosis. Pediatrics. 1965;35:405–12.CrossRefPubMed Carson MJ, Chadwick DL, Brubaker CL, Cleland RS, Landing BH. Thirteen boys with progressive septic granulomatosis. Pediatrics. 1965;35:405–12.CrossRefPubMed
16.
Zurück zum Zitat Kim SJ, Kim JG, Yu YS. Chorioretinal lesions in patients with chronic granulomatous disease. Retina. 2003;23:360–5.CrossRefPubMed Kim SJ, Kim JG, Yu YS. Chorioretinal lesions in patients with chronic granulomatous disease. Retina. 2003;23:360–5.CrossRefPubMed
17.
Zurück zum Zitat Soler-Palacin P, Margareto C, Llobet P, et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol. 2007;35:83–9.CrossRef Soler-Palacin P, Margareto C, Llobet P, et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol. 2007;35:83–9.CrossRef
18.
Zurück zum Zitat Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348:2416–22.CrossRefPubMed Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348:2416–22.CrossRefPubMed
19.
Zurück zum Zitat Weening RS, Kabel P, Pijman P, Roos D. Continuous therapy with sulfamethoxazole-trimethorpim in patients with chronic granulomatous disease. J Pediatr. 1983;103:127–30.CrossRefPubMed Weening RS, Kabel P, Pijman P, Roos D. Continuous therapy with sulfamethoxazole-trimethorpim in patients with chronic granulomatous disease. J Pediatr. 1983;103:127–30.CrossRefPubMed
20.
Zurück zum Zitat Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162:723–6.CrossRefPubMed Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162:723–6.CrossRefPubMed
21.
Zurück zum Zitat International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324:509–16.CrossRef International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324:509–16.CrossRef
22.
Zurück zum Zitat Chiesa R, Wang J, Blok H-J, et al. Hematopoietic stem cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood. 2020;136(10):1201–11.CrossRefPubMed Chiesa R, Wang J, Blok H-J, et al. Hematopoietic stem cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood. 2020;136(10):1201–11.CrossRefPubMed
24.
Zurück zum Zitat Keller MD, Notarangelo LD, Malech HL. Future of care for patients with chronic granulomatous disease: gene therapy and targeted molecular medicine. J Pediatr Infect Dis Soc. 2018;7(Suppl 1):S40–4.CrossRef Keller MD, Notarangelo LD, Malech HL. Future of care for patients with chronic granulomatous disease: gene therapy and targeted molecular medicine. J Pediatr Infect Dis Soc. 2018;7(Suppl 1):S40–4.CrossRef
25.
Zurück zum Zitat Bortoletto P, Lyman K, Camacho A, Fricchione M, Khanolkar A, Katz BZ. Chronic granulomatous disease: a large, single-center US Experience. Pediatr Infect Dis J. 2015;34(10):1110–4.CrossRefPubMedPubMedCentral Bortoletto P, Lyman K, Camacho A, Fricchione M, Khanolkar A, Katz BZ. Chronic granulomatous disease: a large, single-center US Experience. Pediatr Infect Dis J. 2015;34(10):1110–4.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat O’Gorman MR, Corrochano V. Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease. Clin Diagn Lab Immunol. 1995;2:227–32.CrossRefPubMedPubMedCentral O’Gorman MR, Corrochano V. Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease. Clin Diagn Lab Immunol. 1995;2:227–32.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Crockard AD, Thompson JM, Boyd NAM, Haughton DJ, McCluskey DR, Turner CP. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry. Int Arch All Immunol. 1997;114:144–52.CrossRef Crockard AD, Thompson JM, Boyd NAM, Haughton DJ, McCluskey DR, Turner CP. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry. Int Arch All Immunol. 1997;114:144–52.CrossRef
28.
Zurück zum Zitat Haidar G, Zerbe CS, Cheng M, Zelazny AM, Holland SM, Sheridan KR. Phellinus species: an emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease, Mycoses 2017;60:155-60 Haidar G, Zerbe CS, Cheng M, Zelazny AM, Holland SM, Sheridan KR. Phellinus species: an emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease, Mycoses 2017;60:155-60
30.
Zurück zum Zitat Balasubramaniam S, Ruddock CM, Bennetts B, Peters G, Wilcken B, Ellaway C. Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency. Mol Genet Metab. 2010;99:34–41.CrossRefPubMed Balasubramaniam S, Ruddock CM, Bennetts B, Peters G, Wilcken B, Ellaway C. Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency. Mol Genet Metab. 2010;99:34–41.CrossRefPubMed
31.
Zurück zum Zitat Marciano BE, Zerbe CS, Falcone EL, et al. X-linked carriers of chronic granulomatous disease. J All Clin Immunol. 2018;141(1):365–71.CrossRef Marciano BE, Zerbe CS, Falcone EL, et al. X-linked carriers of chronic granulomatous disease. J All Clin Immunol. 2018;141(1):365–71.CrossRef
32.
Zurück zum Zitat Feld JJ, Hussain N, Wright E, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology. 2008;134(7):19017–26.CrossRef Feld JJ, Hussain N, Wright E, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology. 2008;134(7):19017–26.CrossRef
33.
Zurück zum Zitat Gungor T, Teira P, Slatter G, et al. Reduced-intensity conditioning and HLA-matched haematopoetic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383:436–48.CrossRefPubMed Gungor T, Teira P, Slatter G, et al. Reduced-intensity conditioning and HLA-matched haematopoetic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383:436–48.CrossRefPubMed
34.
Zurück zum Zitat Falcone EL, Holland SM. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr Opinion Infect Dis. 2012;25(6):658–69.CrossRef Falcone EL, Holland SM. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr Opinion Infect Dis. 2012;25(6):658–69.CrossRef
35.
Zurück zum Zitat Goldblatt D, Butcher J, Thrasher AJ, Russei-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134:780–3.CrossRefPubMed Goldblatt D, Butcher J, Thrasher AJ, Russei-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134:780–3.CrossRefPubMed
36.
Zurück zum Zitat Al-Muhsen S, Al Hemidan A, Al-Shehri A, et al. Ocular manifestations in chronic granulomatous disease in Saudi Arabia. J Amer Assoc Pediatr Ophthalmol Strabismus. 2009;13:396–9.CrossRef Al-Muhsen S, Al Hemidan A, Al-Shehri A, et al. Ocular manifestations in chronic granulomatous disease in Saudi Arabia. J Amer Assoc Pediatr Ophthalmol Strabismus. 2009;13:396–9.CrossRef
37.
Zurück zum Zitat Dror S, Bruns G, McGee T, Sandberg M, Searson E, Dryja T. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Invest Ophthalmol Vis Sci. 2000;40(9):2712–21. Dror S, Bruns G, McGee T, Sandberg M, Searson E, Dryja T. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Invest Ophthalmol Vis Sci. 2000;40(9):2712–21.
38.
Zurück zum Zitat Flaxel C, Jay M, Thiselton D, et al. Difference between RP2 and RP3 phenotypes in X-linked retinitis pigmentosa. British J Ophthalmol. 1999;83:1144–8.CrossRef Flaxel C, Jay M, Thiselton D, et al. Difference between RP2 and RP3 phenotypes in X-linked retinitis pigmentosa. British J Ophthalmol. 1999;83:1144–8.CrossRef
39.
Zurück zum Zitat Coman D, Yaplito-Lee J, La P et al. Three Mendelian disorders (chronic granulomatous disease, retinitis pigmentosa, ornithine transcarbamalase deficiency) in a young woman with an X chromosome deletion, del(X)(p11.4p21.1) Mol Gen Metab 2010;99:329;l Coman D, Yaplito-Lee J, La P et al. Three Mendelian disorders (chronic granulomatous disease, retinitis pigmentosa, ornithine transcarbamalase deficiency) in a young woman with an X chromosome deletion, del(X)(p11.4p21.1) Mol Gen Metab 2010;99:329;l
40.
Zurück zum Zitat Brandrup F, Koch C, Petri M, Schiodt M, Johansen KS. Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. Brit J Dermatol. 1981;104:495–505.CrossRef Brandrup F, Koch C, Petri M, Schiodt M, Johansen KS. Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. Brit J Dermatol. 1981;104:495–505.CrossRef
Metadaten
Titel
Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized Features
Publikationsdatum
13.06.2022
Erschienen in
Journal of Clinical Immunology / Ausgabe 7/2022
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01294-6

Weitere Artikel der Ausgabe 7/2022

Journal of Clinical Immunology 7/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.